A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1720-1722

  Knecht, Margrith E ^a   Mayr, Michael ^a   Ferrari, Silvia ^b   Scheiflinger, Friedrich ^b   Trendelenburg, Marten ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

ADAMTS13; Autoantibodies; SLE; TTP

Indexed keywords

ANTIBODY; BILIRUBIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; CYCLOPHOSPHAMIDE; HEMOGLOBIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NON NEUTRALIZING ANTIBODY; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE ANTIBODY;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ANASARCA; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; BLURRED VISION; BRAIN VASCULITIS; CARDIOMEGALY; CASE REPORT; COMPLEMENT BLOOD LEVEL; COOMBS TEST; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSPNEA; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPOKINESIA; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY INFARCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MALAISE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; PLASMAPHERESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN DEPLETION; RASH; RHINITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSTHORACIC ECHOCARDIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS;

ADAM PROTEINS; ADULT; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOTIC MICROANGIOPATHIES;

EID: 77951691119     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq021     Document Type: Article

References (10)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600
2. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 340: 1585-1594 (Pubitemid 28536133)
3. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. N Engl J Med 1998; 339: 1578-1584 (Pubitemid 28536132)
4. Rieger M, Mannucci PM, Kremer Hovinga JA, et al. ADAMTS13 autoantibodies in patients with thrombotic micronagiopathies and other immuno mediated diseases. Blood 2005; 106: 1262-1267 (Pubitemid 41129589)
5. Scheiflinger F, Knöbl P, Trattner B, et al. Non neutralising IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 2003; 102: 3241-3243 (Pubitemid 37314762)
6. Rieger M, Ferrari S, Kremer Hovinga JA, et al. Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost 2006; 95: 212-220
7. Ferrari S, Scheiflinger F, Rieger M, et al. Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity. Blood 2007; 109: 2815-2822 (Pubitemid 46482076)
8. Ferrari S, Mudde GC, Rieger M, et al. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired throm-botic thrombocytopenic purpura. J Thromb Haemost 2009; 7: 1703-1710
9. Bianchi V, Robles R, Alberio L, et al. Von Willebrand factor-cleaving protease (ADAMTS13) in thombocytopenic disorders: a sever deficient activity is specific in thrombotic thrombocytopenic purpura. Blood 2002; 100: 710-713 (Pubitemid 34761143)
10. Furlan M, Robles R, Solenthaler M, et al. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998; 91: 2839-2846 (Pubitemid 28227534)